NEW Fast track funding for developing COVID-19 biosensors for skin or oral cavities

Preapplications DUE Wednesday September 9, 2020, 5:00 pm

Full RFA attached

The Washington Entrepreneurial Research Evaluation & Commercialization Hub (WE-REACH) is announcing fast track funding for early-stage projects aimed at developing biosensors for COVID-19 open to researchers in the Pacific Northwest. This one-time opportunity through the NIH is part of the Emergency RADx-Rad initiative to detect the virus or other biomarkers in nasal and oral cavities or skin.

This funding is intended to support innovators with promising technologies and identified biomarkers for early-stage product concept development (R&D) by providing support and project tracking. Each applicant may request up to $434K for 2 years.

This funding is not for discovery research or for identification of new biomarkers. Biosensing devices are expected to target skin or the oral cavity as sampling sites. Skin biosensing designs must target detection of volatile organic compounds (VOCs, i.e. scents or odors) emanating from skin in passive and noninvasive manner for use at point of care. In addition to VOCs, oral biosensing technologies may target a wealth of biological, chemical and physical biosignatures representative of SARS-CoV-2 virus and/or COVID-19 disease sampled from exhaled breath/droplets, saliva, and tissues in the oral cavity using a variety of detection schemes.

Projects must have the infrastructure to rapidly report study findings to the RADx-Rad Data Coordinating Center. Researchers applying to this funding opportunity are strongly encouraged to also review the Data Coordinating Center (DCC) funding opportunity (RFA-OD-20-019), 

Researchers apply through WE-REACH. Other RADx-Rad opportunities for small companies and institutional initiatives are below. Applicants in those categories apply directly to NIH. (Pre-SBIR institutional researchers) (U18 for cooperative submissions) (R44 SBIR Phase II) (R42 STTR Phase II)

For more information and submission information see

Print Friendly, PDF & Email

Leave a reply

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>